Also trades as: GREY.CN (CNQ) · $vol 0M
AGNPF OTC
Grey Matters Health Inc.
1W: -18.5%
1M: -40.4%
3M: -22.0%
YTD: -45.9%
1Y: -50.0%
3Y: -81.2%
5Y: -98.7%
$0.25
+0.00 (+0.32%)
Weekly Expected Move ±19.7%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.4M
52W Range0.2183-0.64
Volume500
Avg Volume12,059
Beta0.29
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher J. Moreau
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2016-03-11
Websitegreymatters-health.com
601 West Broadway
Vancouver, BC V5Z 4C2
CA
Vancouver, BC V5Z 4C2
CA
+1 604 398 4175
About Grey Matters Health Inc.
Grey Matters Health, Inc. is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them into new human trials, developing new formulations and seeking new regulatory approvals in global markets. It specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. The company was founded on January 22, 2015 and is headquartered in Vancouver, Canada.
Latest News
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering
Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building
Recent Insider Trades
No insider trades found